Anand Reddi
| Anand Reddi | |
|---|---|
 |
|
| Born | Maryland, USA |
| Institutions | University of Colorado |
| Alma mater | University of Michigan |
| Known for |
Global Health PEPFAR HIV/AIDS Cancer Research Skin Cancer Metastasis |
| Notable awards | Fulbright Scholar |
Anand Reddi is a researcher and global health specialist. He is known for his scholarly work on U.S. Global Health Policy including the President's Emergency Plan for AIDS Relief (PEPFAR). His basic science research focuses on the molecular mechanisms involved in skin squamous cell cancer tumor initiation and metastasis. In 2005, Reddi was a Fulbright Scholar to South Africa. He served on the board of directors of the AIDS Healthcare Foundation from 2009-11.
Anand Reddi is a graduate of the University of Michigan in Ann Arbor. He received a Fulbright Fellowship to South Africa assisting the Sinikithemba HIV/AIDS Center at McCord Hospital in Durban, KwaZulu-Natal. He studied medicine at the University of Colorado School of Medicine.
Reddi's research focuses on the provision of antiretroviral therapy in resource limited settings. His research in collaboration with Sarah Leeper resulted in one of the first studies that demonstrated that pediatric antiretroviral therapy is effective despite the challenges of a resource limited setting.
Reddi is a featured blogger on The Huffington Post writing on global health and U.S. domestic healthcare issues. In 2010 Reddi published an opinion-editorial article that brought attention to the flat-lining of global AIDS funds by U.S. President Barack Obama's administration. Within six hours, Ezekiel Emanuel, then senior adviser to President Obama for Health Policy, responded directly to Reddi by writing in the Huffington Post: "Contrary to what Dr. Reddi argues, neither I nor the Obama Administration sees an "either-or" trade-off between PEPFAR and other global health priorities such as improving maternal-child health." Reddi rebutted Emanuel's op-ed with a follow-up post that resulted in the restoration of $366 million for antiretroviral scale-up in Uganda.
...
Wikipedia